Back
Keysight Technologies, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Buy
79
KEYS
Keysight Technologies, Inc.
Last Price:
$208.77
Seasonality Move:
2.34%
Buy
75
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$113.50
Seasonality Move:
-9.01%
Buy
79
Keysight Technologies, Inc. (KEYS)
is a Buy
Is Keysight Technologies, Inc. a Buy, Sell or Hold?
-
The current Keysight Technologies, Inc. [KEYS] share price is $214.14. The Score for KEYS is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
-
KEYS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $117.62. The Score for RYTM is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KEYS Stock Price Chart
What is Keysight Technologies, Inc.'s stock price today?
-
The Keysight Technologies, Inc. share price today is $214.14The current trend is moderately bullish and KEYS is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $117.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
KEYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.75 | Buy |
| Relative Strength Index (14 RSI): | 77.47 | Buy |
| Chaikin Money Flow: | 593355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.17 | Buy |
| Relative Strength Index (14 RSI): | 65.29 | Buy |
| Chaikin Money Flow: | 622990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
KEYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 209.32 | Buy |
| 20-day SMA: | 193.2 | Buy |
| 50-day SMA: | 180.89 | Buy |
| 200-day SMA: | 164.4 | Buy |
| 8-day EMA: | 208.13 | Buy |
| 20-day EMA: | 197.89 | Buy |
| 50-day EMA: | 185.91 | Buy |
| 200-day EMA: | 169.95 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.58 | Buy |
| 20-day SMA: | 104.18 | Buy |
| 50-day SMA: | 104.81 | Buy |
| 200-day SMA: | 81.44 | Buy |
| 8-day EMA: | 107.12 | Buy |
| 20-day EMA: | 105.38 | Buy |
| 50-day EMA: | 103.54 | Buy |
| 200-day EMA: | 86.38 | Buy |
Keysight Technologies, Inc. Earnings Growth & KEYS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.29 per share, an increase this year of $0.89 per share, and an increase next year of $1.01 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
Keysight Technologies, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||